These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 15979197)

  • 1. Distribution kinetics of 18F-DOPA in weaver mutant mice.
    Sharma SK; Ebadi M
    Brain Res Mol Brain Res; 2005 Sep; 139(1):23-30. PubMed ID: 15979197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10.
    Sharma SK; El Refaey H; Ebadi M
    Brain Res Bull; 2006 Jun; 70(1):22-32. PubMed ID: 16750479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo biodistribution of no-carrier-added 6-18F-fluoro-3,4-dihydroxy-L-phenylalanine (18F-DOPA), produced by a new nucleophilic substitution approach, compared with carrier-added 18F-DOPA, prepared by conventional electrophilic substitution.
    Kuik WJ; Kema IP; Brouwers AH; Zijlma R; Neumann KD; Dierckx RA; DiMagno SG; Elsinga PH
    J Nucl Med; 2015 Jan; 56(1):106-12. PubMed ID: 25500826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel amphiphilic probes for [18F]-radiolabeling preformed liposomes and determination of liposomal trafficking by positron emission tomography.
    Urakami T; Akai S; Katayama Y; Harada N; Tsukada H; Oku N
    J Med Chem; 2007 Dec; 50(26):6454-7. PubMed ID: 18052025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The distribution and kinetics of [18F]6-fluoro-3-O-methyl-L-dopa in the human brain.
    Wahl L; Chirakal R; Firnau G; Garnett ES; Nahmias C
    J Cereb Blood Flow Metab; 1994 Jul; 14(4):664-70. PubMed ID: 8014214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ¹⁸F-DOPA PET/computed tomography imaging.
    Chondrogiannis S; Marzola MC; Rubello D
    PET Clin; 2014 Jul; 9(3):307-21. PubMed ID: 25030394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo.
    Haase C; Bergmann R; Fuechtner F; Hoepping A; Pietzsch J
    J Nucl Med; 2007 Dec; 48(12):2063-71. PubMed ID: 18056335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging of herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk reporter gene expression in mice and humans using [18F]FHBG.
    Yaghoubi SS; Gambhir SS
    Nat Protoc; 2006; 1(6):3069-75. PubMed ID: 17406570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced cerebral fluoro-L-dopamine uptake in adult patients suffering from phenylketonuria.
    Landvogt C; Mengel E; Bartenstein P; Buchholz HG; Schreckenberger M; Siessmeier T; Scheurich A; Feldmann R; Weglage J; Cumming P; Zepp F; Ullrich K
    J Cereb Blood Flow Metab; 2008 Apr; 28(4):824-31. PubMed ID: 17971791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent.
    Plisson C; Stehouwer JS; Voll RJ; Howell L; Votaw JR; Owens MJ; Goodman MM
    J Med Chem; 2007 Sep; 50(19):4553-60. PubMed ID: 17705359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-step, "one-pot" radiosynthesis of 6-fluoro-3,4-dihydroxy-L-phenylalanine by isotopic exchange.
    Wagner FM; Ermert J; Coenen HH
    J Nucl Med; 2009 Oct; 50(10):1724-9. PubMed ID: 19759110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatic radiofluorination with [18F]fluorine gas: 6-[18F]fluoro-L-dopa.
    Firnau G; Chirakal R; Garnett ES
    J Nucl Med; 1984 Nov; 25(11):1228-33. PubMed ID: 6436449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 4-(5-[18F]fluoromethyl-3-phenylisoxazol-4-yl)benzenesulfonamide, a new [18F]fluorinated analogue of valdecoxib, as a potential radiotracer for imaging cyclooxygenase-2 with positron emission tomography.
    Toyokuni T; Kumar JS; Walsh JC; Shapiro A; Talley JJ; Phelps ME; Herschman HR; Barrio JR; Satyamurthy N
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4699-702. PubMed ID: 16153836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT.
    Beauregard JM; Croteau E; Ahmed N; van Lier JE; Bénard F
    J Nucl Med; 2009 Jan; 50(1):100-7. PubMed ID: 19091905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [18F]-DOPA positron emission tomography for preoperative localization in congenital hyperinsulinism.
    Mohnike K; Blankenstein O; Minn H; Mohnike W; Fuchtner F; Otonkoski T
    Horm Res; 2008; 70(2):65-72. PubMed ID: 18547951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis and determination for enantiomeric purity of 6-fluoro-L-DOPA].
    Tang GH; Zhang L; Tang XL; Wang YX; Yin DZ
    Yao Xue Xue Bao; 2001 Oct; 36(10):739-42. PubMed ID: 12579971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New rapid analysis method demonstrates differences in 6-[18F] fluoro-L-dopa plasma input curves with and without carbidopa and in hemi-MPTP lesioned monkeys.
    McLellan CA; Doudet DJ; Brücke T; Aigner TG; Cohen RM
    Int J Rad Appl Instrum A; 1991; 42(9):847-54. PubMed ID: 1657833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [18F]Fluoro-L-dopa PET/CT in congenital hyperinsulinism.
    Subramaniam RM; Karantanis D; Peller PJ
    J Comput Assist Tomogr; 2007; 31(5):770-2. PubMed ID: 17895790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and preliminary evaluation of (S)-(2-[18F]fluoro-4,5-dihydroxyphenyl)-2-methyl L-alanine, (S)-[18F]-FMEDOPA, a potentially improved imaging agent for the presynaptic dopaminergic nervous system.
    Yost Y; Conway T
    Nucl Med Biol; 1996 Oct; 23(7):857-65. PubMed ID: 8971852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.